While the methylation of SOX1 and ZNF177 was not a statistically significant indicator of overall survival, the combination of these two genes could improve the sensitivity (23% to 39.7%) when discriminating 151 CRC tissues from nontumor tissues. This evidence concerns the gene SOX1 and colorectal carcinoma.